Since its establishment in 2011, Baoteng Biotechnology has planned to utilize scientific methods to cultivate and mass-produce Antrodia cinnamomea fruiting bodies, while simultaneously mass-producing mycelium raw materials with specific active ingredients through innovative technologies such as gene expression and biological fermentation. Antrodia cinnamomea is a precious fungus species unique to Taiwan. In recent years, both its fruiting bodies and mycelia have been proven by numerous domestic and foreign research institutions to possess active efficacy and high safety, making them fully qualified to serve as Taiwan's representative health food raw materials to enter overseas markets.

In order to provide the consumer market with high-quality Antrodia cinnamomea raw materials and health products, Baoteng Biotechnology has already cooperated with multiple domestic and foreign medical university research institutions to conduct relevant trials such as the verification of the active ingredients and efficacy of Antrodia cinnamomea. In the future, Baoteng will follow Good Agricultural Practices (GAP) to establish a production traceability system for Antrodia cinnamomea fruiting bodies and obtain Traceable Agricultural Product (TAP) certification, while mycelium raw materials will be produced and manufactured in cooperation with domestic food GMP factories to ensure product quality. The related series of Antrodia cinnamomea health products will follow the Food Sanitation Management Act and health food regulations to obtain health food certification numbers.